NOVOMIX 30 FLEXPEN 3mL 30% soluble insulin aspart (rys) and 70% insulin aspart (rys) crystallised with protamine 300U/3mL injection syringe Australia - engelsk - Department of Health (Therapeutic Goods Administration)

novomix 30 flexpen 3ml 30% soluble insulin aspart (rys) and 70% insulin aspart (rys) crystallised with protamine 300u/3ml injection syringe

novo nordisk pharmaceuticals pty ltd - insulin aspart, quantity: 100 u/ml - injection, suspension - excipient ingredients: hydrochloric acid; zinc; metacresol; water for injections; glycerol; sodium chloride; protamine sulfate; sodium hydroxide; dibasic sodium phosphate dihydrate; phenol - treatment of diabetes mellitus.

NOVOMIX 30 PENFILL 3mL 30% soluble insulin aspart (rys) and 70% insulin aspart (rys) crystallised with protamine 300U/3mL injection cartridge Australia - engelsk - Department of Health (Therapeutic Goods Administration)

novomix 30 penfill 3ml 30% soluble insulin aspart (rys) and 70% insulin aspart (rys) crystallised with protamine 300u/3ml injection cartridge

novo nordisk pharmaceuticals pty ltd - insulin aspart, quantity: 100 u/ml - injection, suspension - excipient ingredients: zinc; dibasic sodium phosphate dihydrate; protamine sulfate; metacresol; sodium chloride; sodium hydroxide; glycerol; phenol; hydrochloric acid; water for injections - treatment of diabetes mellitus.

Insulin aspart Sanofi Den europeiske union - latvisk - EMA (European Medicines Agency)

insulin aspart sanofi

sanofi winthrop industrie - insulin aspart - cukura diabēts - cukura diabēts - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

NOVOMIX 50 FlexPen 3mL 50% soluble insulin aspart (rys) and 50% insulin aspart (rys) crystallised with protamine 300U/3mL injection syringe Australia - engelsk - Department of Health (Therapeutic Goods Administration)

novomix 50 flexpen 3ml 50% soluble insulin aspart (rys) and 50% insulin aspart (rys) crystallised with protamine 300u/3ml injection syringe

novo nordisk pharmaceuticals pty ltd - insulin aspart, quantity: 100 u/ml - injection, suspension - excipient ingredients: glycerol; metacresol; sodium chloride; dibasic sodium phosphate dihydrate; hydrochloric acid; phenol; zinc; water for injections; sodium hydroxide; protamine sulfate - treatment of diabetes mellitus.

Insulin aspart Sanofi Den europeiske union - polsk - EMA (European Medicines Agency)

insulin aspart sanofi

sanofi winthrop industrie - insulina aspart - cukrzyca - leki stosowane w cukrzycy - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

Insulin aspart Sanofi Den europeiske union - slovensk - EMA (European Medicines Agency)

insulin aspart sanofi

sanofi winthrop industrie - insulin aspart - sladkorna bolezen - zdravila, ki se uporabljajo pri diabetesu - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

Insulin aspart Sanofi Den europeiske union - svensk - EMA (European Medicines Agency)

insulin aspart sanofi

sanofi winthrop industrie - insulin aspart - diabetes mellitus - läkemedel som används vid diabetes - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

Insulin aspart Sanofi Den europeiske union - dansk - EMA (European Medicines Agency)

insulin aspart sanofi

sanofi winthrop industrie - insulin aspart - diabetes mellitus - narkotika anvendt i diabetes - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

Insulin aspart Sanofi Den europeiske union - nederlandsk - EMA (European Medicines Agency)

insulin aspart sanofi

sanofi winthrop industrie - insuline aspart - suikerziekte - geneesmiddelen die worden gebruikt bij diabetes - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

Insulin aspart Sanofi Den europeiske union - italiensk - EMA (European Medicines Agency)

insulin aspart sanofi

sanofi winthrop industrie - insulina aspart - diabete mellito - farmaci usati nel diabete - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.